Researcher.Life Logo

Revista de Literatura : Impact Factor & More

eISSN: 1988-4192pISSN: 0034-849X
JournalOpen Access

Key Metrics

CiteScore
0.3
SNIP
0.79
Recommended pre-submission checks
Powered by Paperpal by Editage

Revista de Literatura Journal Specifications

Overview
Publisher CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC
Language Spanish
Frequency Semi-annual
Publication Time48
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageSpanish
FrequencySemi-annual
Publication Start Year1952
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 48
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo,Dulcinea
License typeCC BY
OA statementVisit website
View less

Planning to publish in Revista de Literatura ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revista de Literatura

Toll-like receptor 7 constrains efferocytosis in myocardial injury.
  • 15 May 2026
  • Basic research in cardiology
Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.
  • 27 Apr 2026
  • Basic research in cardiology
Deubiquitinase USP43 exacerbates myocardial ischemia-reperfusion injury by stabilizing ASK1 and activating the JNK/P38 MAPK pathway.
  • 21 Apr 2026
  • Basic research in cardiology
Analyzing the role of ATP-dependent potassium channels in the regulation of coronary metabolic vasodilation during exercise.
  • 20 Apr 2026
  • Basic research in cardiology
Call for candidates: Editor-in-Chief Basic Research in Cardiology.
  • 17 Apr 2026
  • Basic research in cardiology
Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.
  • 17 Apr 2026
  • Basic research in cardiology
Toll-like receptor 7 constrains efferocytosis in myocardial injury.
  • 15 May 2026
  • Basic research in cardiology
Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.
  • 27 Apr 2026
  • Basic research in cardiology
Deubiquitinase USP43 exacerbates myocardial ischemia-reperfusion injury by stabilizing ASK1 and activating the JNK/P38 MAPK pathway.
  • 21 Apr 2026
  • Basic research in cardiology
Analyzing the role of ATP-dependent potassium channels in the regulation of coronary metabolic vasodilation during exercise.
  • 20 Apr 2026
  • Basic research in cardiology
Call for candidates: Editor-in-Chief Basic Research in Cardiology.
  • 17 Apr 2026
  • Basic research in cardiology
Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.
  • 17 Apr 2026
  • Basic research in cardiology

FAQs on Revista de Literatura